About
Peptinovo develops a smart drug delivery platform focused on improving the efficacy and reducing side effects of chemotherapy drugs to treat solid tumors. Their pipeline includes multiple chemotherapy drugs leveraging their patented PALM™ carrier technology, with their lead candidate PNB-281 undergoing pre-IND enabling testing.
Explore Peptinovo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.